Last reviewed · How we verify
NCT04182477: MCI
Age and Number of Previous Anesthesia on the Development of Mild Cognitive Decline (MCI)
trial testing Montreal Cognitive Assessment in Mild Cognitive Impairment in 168 participants. Completed in 15 September 2023.
28 August 2023
Quick facts
| Lead sponsor | University of Padova |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 168 |
| Start date | 7 January 2019 |
| Primary completion | 28 August 2023 |
| Estimated completion | 15 September 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Montreal Cognitive Assessment
Conditions studied
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Sponsor
University of Padova
Who can join
Adults 18 to 99, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mild Cognitive Impairment (MCI), diagnosed with Montreal Cognitive assessment test (MoCA) define a condition that is insufficient to meet the threshold for a diagnosis of dementia, and it is an increasing health problem. It has been related to age and comorbilities, but the linkage between MCI and number of previous anesthesia is still unclear.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Influence of Previous General Anesthesia on Cognitive Impairment: An Observational Study Among 151 Patients.
Linassi F, De Laurenzis A, Maran E, Gadaldi A, et al · · 2022 · cited 3× · PMID 35652004 · DOI 10.3389/fnhum.2022.810046
Verify or expand the search:
- PubMed search for NCT04182477
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Montreal Cognitive Assessment
Trials testing the same drug.
- NCT06869304 — The Effect of Steep Trendelenburg Position on Neurocognitive Functions in Robotic Radical Prostatectomy Cases · not yet recruiting
- NCT06441136 — Characterizing the Impact of Presbyphonia on Social Interaction · NA · recruiting
- NCT05890313 — Improving the Referral of Patients With Suspected Cognitive Impairment and Early Dementia · NA · not yet recruiting
- NCT06045598 — Postural Control, Ankle and Trunk Proprioception in Type 2 Diabetes · unknown
- NCT06044207 — Biomarkers and Risk Factors for Perioperative Neurocognitive Dysfunction in Elderly Patients · unknown
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
- NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting
Other University of Padova trials
Trials by the same sponsor.
- NCT07435064 — NURsing-led FRAILty Prevention and Care · NA · not yet recruiting
- NCT07283354 — Comparison of Acceleromyography and Electromyography in Obese Patients Undergoing General Anesthesia · not yet recruiting
- NCT07259460 — Effects of Dexmedetomidine Target Controlled Infusion on Patient State Index Values and Electroencephalographic Spectrum · recruiting
- NCT07385118 — Daily Fluctuations in Brain-Derived Neurotrophic Factor and Cognition: Effects of Vigorous Exercise · NA · completed
- NCT07259291 — Minto and Eleveld Remifentanil Target Controlled Infusion (TCI) Models: a Clinical Comparison · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04182477 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Padova
- Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04182477.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing